About Droplet Biosciences
Droplet Biosciences is a private company based in Cambridge, Massachusetts, incorporated in 2021 in Delaware. It has reported $12,962,954 raised in two offerings on Form D since May 2021. Its chief executive is Theresa Tribble.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 28, 2023 | Dec 13, 2023 | $7,613,974of $14.1M target | 21 | $362K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| May 21, 2021 | May 28, 2021 | $5,348,980fully sold | 30 | $178K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $12,962,954 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Droplet Biosciences's Form D filed Dec 13, 2023.
RS
Rachel Sha
Director
Also a director at Axoft and Lucy Therapeutics and a chief executive officer, board member at Terrestrial.
SL
Stanley Lapidus
Director
TT
Theresa Tribble
Chief Executive Officer and director
AD
Ann DeWitt
Director
JZ
Jose Zevallos
Director
Earlier filings also listed Aadel Chaudhuri (executive officer and director, last listed May 2021).